Back
Supernus Pharmaceuticals Stock Predictions
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
SUPN
Supernus Pharmaceuticals
Last Price:
31.97
Seasonality Move:
-9.35%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Supernus Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 19.3% based on the past 12 years of stock performance.
- Supernus Pharmaceuticals has risen higher in 7 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%
-
Is Supernus Pharmaceuticals Stock Undervalued?
The current Supernus Pharmaceuticals [SUPN] share price is $31.84. The Score for SUPN is 25, which is 50% below its historic median score of 50, and infers higher risk than normal. - SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 19.3% based on the past 12 years of stock performance.
Supernus Pharmaceuticals Stock Rating
Sell
25
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals overpriced?
- Supernus Pharmaceuticals has risen higher in 7 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%
Supernus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
35.44
52-Week Low:
21.99
Prediction Charts
Market Cap:
1.75B
Price in USD:
31.84
Volume:
263.53K
Beta:
1.11
Technical Analysis
SMA50:
31.83
SMA100:
29.84
SMA200:
29.75
52-Wk Change:
12.47%
Stock Predictions
-
Is Supernus Pharmaceuticals stock public?
Yes, Supernus Pharmaceuticals is a publicly traded company. -
What is the Supernus Pharmaceuticals stock quote today?
The Supernus Pharmaceuticals stock price is 31.84 USD today. -
How to buy Supernus Pharmaceuticals stock online?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-29 | 34.90 | 35.00 | 35.10 | 34.63 |
| Aug-30 | 35.11 | 35.16 | 35.18 | 34.57 |
| Sep-3 | 34.90 | 34.71 | 34.93 | 34.39 |
| Sep-4 | 34.74 | 35.00 | 35.02 | 34.30 |
| Sep-5 | 35.11 | 34.39 | 35.15 | 34.31 |
| Sep-6 | 34.26 | 33.86 | 34.46 | 33.54 |
| Sep-9 | 33.75 | 33.90 | 34.27 | 33.50 |
| Sep-10 | 33.87 | 33.49 | 34.13 | 33.25 |
| Sep-11 | 32.71 | 31.08 | 32.75 | 29.50 |
| Sep-12 | 31.24 | 30.88 | 31.57 | 30.73 |
| Sep-13 | 31.22 | 31.11 | 31.62 | 30.99 |
| Sep-16 | 31.34 | 31.48 | 31.87 | 30.78 |
| Sep-17 | 31.62 | 31.72 | 31.95 | 31.58 |
| Sep-18 | 31.64 | 31.84 | 32.59 | 31.59 |
Supernus Pharmaceuticals Earnings
Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals Forecast Revenue Growth
Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.